- NYSE: PLTR has been one of wallstreetbets most discussed stocks in 2021.
- Palantir shares are up 65% for 2021 so far!
- Peter Thiel backed Palantir has a 10% short interest.
Update: Palantir (PLTR) signs multi-year enterprise partnership with Rio Tinto. PLTR shares are surging ahead in Thursday’s pre-market trading on the back of this news breaking through $40!
Update: Wednesday, January 20 – William Blair initiates coverage on PLTR with a market perform rating. The firm is optimistic about strong growth in 2021 but concerned about new US administration.
Previous update: Palantir Technologies Inc (NYSE: PLTR) has been surging over 10% and trades at around $27.50, the highest level since Christmas. Stock analysts are becoming growingly bullish on the analysts firm, despite its secrecy and as it expands its offering. One of the positive factors going for the firm backed by Peter Thiel is that is has contracts with the US government. President-elect Joe Biden presented a $1.9 trillion stimulus plan, and some of these funds may go to the firm.
Update: NASDAQ: PLTR is holding its ground on Wednesday after edging lower on Tuesday. Zooming out of the daily ebb and flow, Palantir's shares are holding onto the $26 area, around the highs for 2021 so far. The recommendation from Jefferies keeps the analysis stock bid. Investors are also encouraged by the firm's involvement in efforts to curb coronavirus, a move away from more secretive defense contracts. Markets prefer more transparency.
Some investors perform their own research – and others jump on studies performed by others. That seems to be the case in the recent rise of Palantir Technologies Inc (NASDAQ: PLTR) which has risen by 2.90% on Monday and is set to gain an additional 1.50% on Tuesday, according to pre-market trading.
The increase to $26.32 would be the fourth consecutive day of gains, but still short of the $30 price target put by Jeffries. Brent Thill, an analyst at the renowned firm, boosted his objective from $18 and maintained his "Buy" recommendation, adding a "Street High" characterization.
Thill also cited the company's unique offering of high-end data analysis and expected robust growth. Not all is known about the company founded by Alex Karp and received investments from Peter Thiel and others. The company came under criticism for its contract with the US Immigration and Customs Enforcement (ICE) over family separations.
Palantir heavily depends on contracts from various branches of the US government, including the Department of Defense. It also has clients in banking and other financial sector companies. The Denver-based company has also had a role in supporting Britain's National Health Service in the current coronavirus crisis.
PLTR Stock Forecast
The $30 level is in sight according to Jeffries, but the road ahead may be more tricky. The firm is already valued at over $45 billion and has suffered a fall in December, partially due to sell recommendations. With that hurdle over, there are still other issues weighing on PLTR.
One concern is the expiry of founders' IPO lockup period – which currently forbids insiders to sell their stock. The chains will fall sometime in February when the company publishes its earnings.
The author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
This article is for information purposes only. The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice. It is important to perform your own research before making any investment and take independent advice from a registered investment advisor.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to accuracy, completeness, or the suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. The author will not be held responsible for information that is found at the end of links posted on this page.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold closes below key $2,318 support, US GDP holds the key
Gold price is breathing a sigh of relief early Thursday after testing offers near $2,315 once again. Broad risk-aversion seems to be helping Gold find a floor, as traders refrain from placing any fresh directional bets on the bright metal ahead of the preliminary reading of the US first-quarter GDP due later on Thursday.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
Meta takes a guidance slide amidst the battle between yields and earnings
Meta's disappointing outlook cast doubt on whether the market's enthusiasm for artificial intelligence. Investors now brace for significant macroeconomic challenges ahead, particularly with the release of first-quarter GDP data.